BAYESIAN-APPROACH TO BIOEQUIVALENCE ASSESSMENT - AN EXAMPLE

被引：50

作者：

FLUEHLER, H

GRIEVE, AP

MANDALLAZ, D

MAU, J

MOSER, HA

机构：

[1] RHEIN WESTFAL TH AACHEN,D-5100 AACHEN,FED REP GER

[2] ESSEX CHEM AG,LUZERN,SWITZERLAND

来源：

关键词：

D O I：

10.1002/jps.2600721018

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1178 / 1181

页数：4

共 7 条

[1]

Belsley d, 1980, REGRESSION DIAGNOSTI

[2]

COCHRAN WG, 1957, EXPT DESIGN

[3]

FLUEHLER H, 1981, J PHARMACOKINET BIOP, V9, P235

MANDALLAZ, D ;

MAU, J .

[5] BIOAVAILABILITY - PROBLEM IN EQUIVALENCE [J].

METZLER, CM .

SELWYN, MR ;

DEMPSTER, AP ;

HALL, NR .

[7] STATISTICAL ASPECTS OF COMPARATIVE BIOAVAILABILITY TRIALS [J].

WESTLAKE, WJ .